RNA binding protein Musashi1 interacts with the viral genomic RNA and restricts SARS-CoV-2 infection by repressing translation
Nucleic Acids Research · 19.03.2026 · 54 (6)
DOI: 10.1093/nar/gkag271 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 31.03.2026. Verfasst von Sourav Ganguli und 10 weiteren Autor:innen. Beteiligte Einrichtung: CSIR-Centre for Cellular and Molecular Biology, Hyderabad, Telangana 500007, India. Hauptthemen laut MEDLINE: RNA-Binding Proteins, RNA, Viral, SARS-CoV-2, Protein Biosynthesis. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Anusandhan Research foundation, Wellcome Trust, Council of Scientific and Industrial Research.
Abstract (Originalsprache)
Musashi RNA-binding proteins are important post-transcriptional regulators of stem cell homeostasis and are known to be involved in viral infections. However, their role in SARS-CoV-2 infection remains largely unknown. Using computational studies, in vivo RNA immunoprecipitation, and biochemical assays, here, we establish that Musashi 1 (Msi1) interacts with viral genomic RNA through direct binding to the SARS-CoV-2 3′UTR. Importantly, binding of Msi1 to the viral 3′UTR results in translational repression that could be mediated by inhibition of poly(A) binding protein. Conversely, Msi1 knockout promotes robust viral replication and increased viral protein expression. Using 2D cell cultures, stem cells, and 3D organoids, we show that depletion of Msi1 in intestinal cells augments infection. This finding explains why the human intestine serves as a reservoir for SARS-CoV-2, in which differentiated enterocytes with negligible Msi1 levels are particularly affected. Contrarily, stem cells, which are enriched for Msi1 expression, are known to be less permissive to SARS-CoV-2 infection despite expressing the entry receptors. Our findings show how translational repression of SARS-CoV-2 by stem cell RNA-binding proteins, such as Msi1, could help evade infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- CSIR-Centre for Cellular and Molecular Biology, Hyderabad, Telangana 500007, India.
- Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, Uttar Pradesh 201002, India.
- Department of Biology, Indian Institute of Science Education and Research (IISER) Tirupati, Tirupati, Andhra Pradesh 517619, India.
ORCID-Profile: Sreenivas Chavali, Pavithra L Chavali
Förderung
- Anusandhan Research foundation
- Wellcome Trust
- Council of Scientific and Industrial Research
- CSIR
- IISER Tirupati
- Department of Biotechnology
- ONOS
- ANRF
Zitieren
APA
Ganguli, S., Gupta, D., Kadumuri, R. V., Tandel, D., Ramaswamy, R., Krishnan, A. G., David, D. T., Bunk, S., Chavali, S., Harshan, K. H., & Chavali, P. L. (2026). RNA binding protein Musashi1 interacts with the viral genomic RNA and restricts SARS-CoV-2 infection by repressing translation. Nucleic Acids Research, 54(6). https://doi.org/10.1093/nar/gkag271
Vancouver
Ganguli S, Gupta D, Kadumuri RV, Tandel D, Ramaswamy R, Krishnan AG, et al. RNA binding protein Musashi1 interacts with the viral genomic RNA and restricts SARS-CoV-2 infection by repressing translation. Nucleic Acids Research. 2026;54(6). doi:10.1093/nar/gkag271
BibTeX
@article{Ganguli2026,
author = {Ganguli, Sourav and Gupta, Divya and Kadumuri, Rajashekar Varma and Tandel, Dixit and Ramaswamy, Rajashree and Krishnan, Aswathy G and David, Deena T and Bunk, Soumya and Chavali, Sreenivas and Harshan, Krishnan Harinivas and Chavali, Pavithra L},
title = {RNA binding protein Musashi1 interacts with the viral genomic RNA and restricts SARS-CoV-2 infection by repressing translation},
journal = {Nucleic Acids Research},
year = {2026},
volume = {54},
number = {6},
doi = {10.1093/nar/gkag271}
}
EUVIMED